|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 883.2 DKK | +0.07% |
|
+1.16% | +26.51% |
| May. 10 | Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows | RE |
| May. 10 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
On March 16, 2021, Glooko, Inc. closed the transaction. The company has issued 22,532,655 shares for gross proceeds of $29,999,999 in the transaction led by new investor Health Catalyst Capital Management, LLC. The transaction involved participation from returning investors, Canaan Partners, Georgian Partners Growth LP, Novo Nordisk A/S, Insulet Corporation, and Mayo Clinic Ventures.
In all 11 investors were involved in the round.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.51% | 568B | |
| +30.38% | 684B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B | |
| -2.71% | 159B |
NOVO NORDISK A/S 
